FALP ( Site 0161)

Santiago, Region M. de Santiago 7500921

3 studies enrolling now · 3 studies all time

What they study most

Lung Neoplasm Malignant, Non-small Cell Lung Cancer

Studies at this site

• A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F) — Recruiting now
• Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01) — Recruiting now
• A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01) — Recruiting now